Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell‐derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.